Lexicon Pharmaceuticals Inc
LXRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.02B
Close$
$-0.39
117.3% downside
Current Fair Value
117.3% downsideOvervalued by 117.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.02 Billion |
|---|---|
| Enterprise Value | $976.28 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.14 |
| Beta | 1.04 |
| Outstanding Shares | 437,653,000 |
Return
| Return on Equity | -35.02% |
|---|---|
| Return on Assets | -24.44% |
| Return on Invested Capital | -24.27% |
Valuation & Multiples
| P/E Ratio | -15.23 |
|---|---|
| PEG | 1.41 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 23.54 |
| Enterprise Value to EBIT | -17.09 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$3.99 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
$2.83 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0221▼ 6.08% |
|---|---|
| Total Calls | 1,620,700▼ 3.06% |
| Total Puts | 35,800▼ 74.17% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 91.58%▲ 10.79% |
|---|---|
| Total Invested | $883.11M▲ 75.03% |
| Investors Holding | 155▲ 14.00% |
ESG Score
No data